Growth Metrics

Resmed (RSMDF) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Resmed (RSMDF) over the last 16 years, with Q4 2025 value amounting to $934.4 million.

  • Resmed's Total Non-Current Liabilities fell 984.09% to $934.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $934.4 million, marking a year-over-year decrease of 984.09%. This contributed to the annual value of $1.2 billion for FY2025, which is 817.31% up from last year.
  • According to the latest figures from Q4 2025, Resmed's Total Non-Current Liabilities is $934.4 million, which was down 984.09% from $931.6 million recorded in Q3 2025.
  • In the past 5 years, Resmed's Total Non-Current Liabilities ranged from a high of $2.2 billion in Q4 2022 and a low of $930.7 million during Q2 2021
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $1.1 billion (2021), whereas its average is $1.3 billion.
  • In the last 5 years, Resmed's Total Non-Current Liabilities plummeted by 4126.91% in 2021 and then surged by 12785.34% in 2022.
  • Quarter analysis of 5 years shows Resmed's Total Non-Current Liabilities stood at $967.8 million in 2021, then surged by 127.85% to $2.2 billion in 2022, then decreased by 24.76% to $1.7 billion in 2023, then plummeted by 37.54% to $1.0 billion in 2024, then dropped by 9.84% to $934.4 million in 2025.
  • Its Total Non-Current Liabilities was $934.4 million in Q4 2025, compared to $931.6 million in Q3 2025 and $1.2 billion in Q2 2025.